Exchange: NASDAQ·Updated 07:00 PM EDT
BIIB logo

BIIBBiogen Inc

$196.58
$2.09
(1.05%)
Today
Closed $196.58
$0.13
(0.07%)
After Hours
EarningsJul 29
Mkt Cap$29.02B
Vol1.73M
46

Neutral Sentiment

How do you feel about BIIB?

About

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7,500

Frequently Asked Questions

What is Market Cap of Biogen Inc?
What is the 52-week high for Biogen Inc?
What is the 52-week low for Biogen Inc?
What is Biogen Inc stock price today?
What was Biogen Inc stock price yesterday?
What is the PE ratio of Biogen Inc?
What is the Price-to-Book ratio of Biogen Inc?
What is the 50-day moving average of Biogen Inc?
How many employees does Biogen Inc have?

Advertisement|Remove ads.